Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11990 | 30655210 | Hipertens Riesgo Vasc | [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. | 2019 | Details |
| A11994 | 30653691 | Hepatology | The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11997 | 30653341 | Am J Physiol Gastrointest Liver Physiol | Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. | 2019 | Details |
| A11999 | 30652642 | Curr Pharm Des | Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts. | 2018 | Details |
| A12011 | 30645665 | Internist (Berl) | [New aspects of nonalcoholic steatohepatitis]. | 2019 | Details |
| A12019 | 30641737 | Diabetes Metab Syndr | Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center. | 2018 | Details |
| A12021 | 30641412 | Mol Immunol | New Aspect of Liver IL-17+γδ T Cells. | 2019 | Details |
| A12023 | 30639779 | Clin Gastroenterol Hepatol | Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2019 | Details |
| A12027 | 30636282 | Eur J Clin Invest | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. | 2019 | Details |
| A12029 | 30635812 | Obes Surg | Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score. | 2019 | Details |
| A12032 | 30633176 | Medicine (Baltimore) | A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates. | 2019 | Details |
| A12033 | 30631885 | Singapore Med J | A practical clinical approach to liver fibrosis. | 2018 | Details |
| A12038 | 30630004 | Life Sci | A maternal high-fat diet may accelerate adipo-immunologic aging in offspring. | 2019 | Details |
| A12043 | 30625517 | Biomed Pharmacother | A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A12044 | 30625508 | Exp Clin Endocrinol Diabetes | Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12045 | 30625487 | Dig Dis | Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12046 | 30625377 | Toxicol Lett | Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. | 2019 | Details |
| A12052 | 30622370 | World J Gastroenterol | Role of cenicriviroc in the management of nonalcoholic fatty liver disease. | 2018 | Details |
| A12057 | 30619993 | Hepatol Commun | Childhood Fructoholism and Fructoholic Liver Disease. | 2018 | Details |
| A12070 | 30616027 | Clin Gastroenterol Hepatol | Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. | 2019 | Details |
| A12081 | 30610213 | Eur J Clin Nutr | The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A12082 | 30609782 | Nutrients | Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A12083 | 30609663 | Cells | Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease. | 2019 | Details |
| A12084 | 30609189 | Liver Transpl | Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. | 2019 | Details |
| A12086 | 30608932 | PLoS One | High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. | 2019 | Details |
| A12087 | 30607807 | Infect Dis Ther | A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? | 2019 | Details |
| A12094 | 30605676 | Cell Rep | Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD. | 2019 | Details |
| A12103 | 30601174 | Curr Opin Clin Nutr Metab Care | Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? | 2019 | Details |
| A12104 | 30600551 | J Gastroenterol Hepatol | HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. | 2019 | Details |
| A12106 | 30600304 | Ann Hepatol | The Evolving Role of Liver Biopsy in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A12109 | 30599172 | J Hepatol | Gap junctions in liver disease: Implications for pathogenesis and therapy. | 2018 | Details |
| A12111 | 30597715 | Liver Int | Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. | 2019 | Details |
| A12113 | 30597154 | Hum Pathol | Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH. | 2018 | Details |
| A12116 | 33442148 | J ASEAN Fed Endocr Soc | Factors associated with the Severity of Findings on Hepatic Transient Elastography among Persons with Type 2 Diabetes and Fatty Liver. | 2019 | Details |
| A12118 | 32821461 | Medeni Med J | Evaluation of Liver Biopsy Findings and Comparison with Noninvasive Fibrosis Scores in Patients with Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A12123 | 30593409 | Med Hypotheses | The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. | 2018 | Details |
| A12124 | 30592792 | J Diabetes Investig | Insulin-like growth factor-1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus. | 2019 | Details |
| A12128 | 30590937 | Vnitr Lek | Transient elastography - role in the assessment of the liver disease development. | 2019 | Details |
| A12129 | 30590868 | J Gastroenterol Hepatol | Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. | 2019 | Details |
| A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A12137 | 30588181 | Int J Med Sci | Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12139 | 30586008 | J Clin Gastroenterol | Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A12141 | 30584660 | Hepatology | Arid1a Loss Drives Nonalcoholic Steatohepatitis in Mice Through Epigenetic Dysregulation of Hepatic Lipogenesis and Fatty Acid Oxidation. | 2019 | Details |
| A12144 | 30582966 | Biochim Biophys Acta Mol Basis Dis | Prognostic molecular markers in pediatric liver disease - Are there any? | 2018 | Details |
| A12147 | 30582764 | Hepatology | Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression. | 2019 | Details |
| A12150 | 30581002 | Biochem Biophys Res Commun | Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1. | 2018 | Details |
| A12154 | 30580090 | Clin Gastroenterol Hepatol | Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation. | 2018 | Details |
| A12164 | 30577089 | Hepatol Res | Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus. | 2019 | Details |
| A12166 | 30576769 | Cell Mol Gastroenterol Hepatol | Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12170 | 30576330 | PLoS One | Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care. | 2018 | Details |
| A12172 | 30574627 | J Gastrointestin Liver Dis | Nonalcoholic Fatty Liver Disease: Status Quo. | 2018 | Details |
| A12185 | 30570529 | J Acquir Immune Defic Syndr | Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study. | 2019 | Details |
| A12187 | 30569636 | Obesity (Silver Spring) | Blackcurrant (Ribes nigrum) Prevents Obesity-Induced Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A12190 | 30568471 | Diabetes Metab Syndr Obes | Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis. | 2018 | Details |
| A12193 | 30567742 | Gut | Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A12196 | 30567081 | BMJ Case Rep | Non-alcoholic steatohepatitis associated with Netherton syndrome. | 2018 | Details |
| A12202 | 30563997 | J Clin Exp Hepatol | Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors. | 2018 | Details |
| A12205 | 30562976 | J Clin Med | Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients. | 2018 | Details |
| A12207 | 30561388 | J Clin Invest | STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. | 2018 | Details |
| A12211 | 30560362 | Eur Radiol | Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model. | 2018 | Details |
| A12213 | 30560336 | Dig Dis Sci | Incidence of Recurrent NASH-Related Allograft Cirrhosis. | 2018 | Details |
| A12214 | 30559861 | Open Access Maced J Med Sci | The Comparison of Simple Anthropometric and Biochemical Parameters for Predicting Liver Steatosis in Obese Balinese Young Women. | 2018 | Details |
| A12224 | 30556038 | Hepatol Commun | Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12225 | 30556037 | Hepatol Commun | Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice. | 2018 | Details |
| A12226 | 30556036 | Hepatol Commun | A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12229 | 30555477 | Front Immunol | Macrophages in the Aging Liver and Age-Related Liver Disease. | 2018 | Details |
| A12231 | 30554783 | Lancet | Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. | 2018 | Details |
| A12242 | 30551263 | J Gastroenterol Hepatol | Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. | 2019 | Details |
| A12244 | 30549292 | Hepatology | Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials. | 2019 | Details |
| A12250 | 30547371 | Adv Ther | Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study. | 2018 | Details |
| A12256 | 30544653 | Int J Mol Sci | miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. | 2018 | Details |
| A12259 | 30543441 | Mol Pharm | Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice. | 2018 | Details |
| A12270 | 30540086 | Arq Gastroenterol | CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. | 2019 | Details |
| A12273 | 30538805 | Oxid Med Cell Longev | c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types. | 2018 | Details |
| A12275 | 30537758 | Digestion | Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research. | 2018 | Details |
| A12277 | 30537674 | Biomed Pharmacother | Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway. | 2018 | Details |
| A12279 | 30536914 | J Physiol | Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. | 2019 | Details |
| A12281 | 30536539 | J Cell Mol Med | The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. | 2018 | Details |
| A12286 | 30529590 | J Hepatol | Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis. | 2018 | Details |
| A12288 | 30528844 | Clin Gastroenterol Hepatol | FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. | 2018 | Details |
| A12291 | 30527903 | Hepatobiliary Pancreat Dis Int | Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. | 2018 | Details |
| A12297 | 30520566 | Obesity (Silver Spring) | Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. | 2018 | Details |
| A12298 | 30520543 | Cancer Sci | Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet. | 2019 | Details |
| A12300 | 30519965 | Acta Diabetol | A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? | 2018 | Details |
| A12301 | 30519850 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. | 2018 | Details |
| A12304 | 30508523 | Biochem Pharmacol | Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. | 2018 | Details |
| A12306 | 30506860 | J Gastroenterol Hepatol | Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index. | 2019 | Details |
| A12307 | 30506692 | Aliment Pharmacol Ther | Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD. | 2018 | Details |
| A12308 | 30506586 | Hepatology | Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. | 2019 | Details |
| A12314 | 30502056 | EBioMedicine | Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study. | 2018 | Details |
| A12315 | 30502049 | Am J Cardiol | Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance. | 2018 | Details |
| A12316 | 30517626 | Endocrinology | Hepatic HKDC1 Expression Contributes to Liver Metabolism. | 2019 | Details |
| A12318 | 30516830 | Hepatology | Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages. | 2019 | Details |
| A12320 | 30516498 | Georgian Med News | EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE. | 2018 | Details |
| A12324 | 30515622 | Obes Surg | Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort. | 2019 | Details |
| A12331 | 30511955 | J Musculoskelet Neuronal Interact | Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? | 2018 | Details |
| A12332 | 30511198 | Dig Dis Sci | Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12339 | 30500887 | Endocr Rev | Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12340 | 30500848 | PLoS One | Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. | 2018 | Details |
| A12343 | 30499266 | J Biomed Opt | Diffuse reflectance spectroscopy accurately discriminates early and advanced grades of fatty liver in mice. | 2018 | Details |